Genfit SA (GNFT)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Genfit SA (GNFT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011724
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s product pipeline comprise GFT505, TGFTX1, TGFTX3, TGFTX4, TGFTX5 and SAN/GFT-2. Its TGFTX1 can be used for the treatment of inflammatory and auto-immune diseases; and TGFTX3 for metabolic and inflammatory diseases. Genfit provides TGFTX4 for fibrotic diseases; and TGFTX5 for the treatment of chronic inflammatory bowel diseases. The company’s research and development activities include multiple drug candidate research programs targeting novel mechanisms of action such as the inhibition of ROR?-t. It has presence in France and the US. Genfit is headquartered in Loos, France.

Genfit SA (GNFT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genfit SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Genfit SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Genfit SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Genfit SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Genfit SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Genfit SA, Medical Equipment, Deal Details 10
Partnerships 10
ImaBiotech Enters Into Agreement With Genfit 10
Equity Offering 11
Genfit Raises USD50 Million in Rights Offering of Shares 11
Genfit Raises USD38 Million Private Placement of Shares 12
Genfit Raises USD54.2 Million in Private Placement of Shares 13
Genfit Raises USD26 Million in Private Placement of Shares 14
Debt Offering 15
Genfit Raises USD212 Million in Private Placement of 3.5% Bonds Due 2022 15
Acquisition 16
Novartis May Acquire Genfit 16
Genfit SA – Key Competitors 17
Genfit SA – Key Employees 18
Genfit SA – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Oct 11, 2017: GENFIT: Third quarter 2017 financial information 20
Sep 25, 2017: Genfit: 2017 Half-Year Results: Cash Position At End Of Period At €126M And Significant Advances In The Company’S Pipeline 21
Apr 24, 2017: Genfit: Q1 2017 Financial Information 26
Nov 08, 2016: GENFIT: Third Quarter 2016 Financial Information 30
Apr 26, 2016: Genfit: First Quarter 2016 Financial Information 31
Feb 04, 2016: Annual Results 2015: End-Of-Year Cash Position Of €60M And Major Progress In The Diagnosis And The Treatment Of Nash 33
Product News 34
Oct 20, 2016: GENFIT announces the acceptance of two new abstracts, including one to be presented in an oral session at the 2016 AASLD meeting 34
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Genfit SA, Medical Equipment, Key Facts, 2016 2
Genfit SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Genfit SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Genfit SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Genfit SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Genfit SA, Deals By Market, 2011 to YTD 2017 8
Genfit SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
ImaBiotech Enters Into Agreement With Genfit 10
Genfit Raises USD50 Million in Rights Offering of Shares 11
Genfit Raises USD38 Million Private Placement of Shares 12
Genfit Raises USD54.2 Million in Private Placement of Shares 13
Genfit Raises USD26 Million in Private Placement of Shares 14
Genfit Raises USD212 Million in Private Placement of 3.5% Bonds Due 2022 15
Novartis May Acquire Genfit 16
Genfit SA, Key Competitors 17
Genfit SA, Key Employees 18
Genfit SA, Subsidiaries 19

★海外企業調査レポート[Genfit SA (GNFT)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • First Interstate Bancsystem, Inc.:企業の戦略・SWOT・財務分析
    SummaryFirst Interstate Bancsystem, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the co …
  • iCAD, Inc. (formerly Howtek, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' iCAD, Inc. (formerly Howtek, In …
  • Capital One Financial Corporation:企業の戦略・SWOT・財務分析
    Capital One Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Capital One Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • SMU S.A. (SMU):企業の財務・戦略的SWOT分析
    SMU S.A. (SMU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • RWE AG (RWE)(エネルギー分野):企業M&A動向
    Summary RWE AG (RWE) is a leading electricity and gas company. The company operates in all stages of the energy value chain. It produces oil, gas and lignite; generates, transmits and distributes electricity; and distributes and supplies gas to customers. The company generates electricity from coal, …
  • Tribune Media Company:戦略・SWOT・企業財務分析
    Tribune Media Company - Strategy, SWOT and Corporate Finance Report Summary Tribune Media Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Galliford Try plc:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Galliford Try plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelligence …
  • Caretech Holdings Plc (CTH):企業の財務・戦略的SWOT分析
    Summary Caretech Holdings Plc (CareTech) is a children and adult care service provider. The company offers solution for adults and solution for children and young people. its adult care services includes learning disability, mental health, acquired brain injury, eating disorders, sensory impairments …
  • Dana-Farber Cancer Institute, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Dana-Farber Cancer Institute, Inc. (Dana-Farber) is a cancer research center. The center offers treatment for different types of cancers. It provides adults and children with various treatment options. The center offers ongoing clinical trials for cancer at Dana-Farber and affiliated institu …
  • National Mobile Telecommunications Company K.S.C.P.:企業の戦略・SWOT・財務情報
    National Mobile Telecommunications Company K.S.C.P. - Strategy, SWOT and Corporate Finance Report Summary National Mobile Telecommunications Company K.S.C.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's stru …
  • Surgical Care Affiliates LLC (SCAI):企業のM&A・提携動向(医療機器分野)
    Summary Surgical Care Affiliates LLC (SCA) is a healthcare organization that offers patient care services. The organization's services include physician governance and engagement, scheduling optimization, staffing optimization, supply chain optimization, and case costing and profitability analysis. …
  • Mercuria Energy Group Ltd:企業のM&A・提携動向(石油・ガス分野)
    Summary Mercuria Energy Group Ltd (Mercuria Energy) is an independent energy and commodity group that carries out sourcing, supplying and trading of crude oil and refined petroleum products through its subsidiaries. Its portfolio includes petrochemicals, biofuels, environmental products, natural gas …
  • BrainCool AB (BRAIN):医療機器:M&Aディール及び事業提携情報
    Summary BrainCool AB (BrainCool), a subsidiary of Dignitana AB, is a medical device company that focuses on developing, and commercializing medical cooling systems for brain cooling and pain management. The company’s products are based on the principle that applying therapeutic hypothermia contribut …
  • Hubei Biocause Pharmaceutical Co., Ltd. (000627):企業概要、財務及び戦略的SWOT分析
    Summary Hubei Biocause Pharmaceutical Co., Ltd. (Hubei Biocause) is a pharmaceutical company. The company operates through API division, Drug product division and Chemical Division. Hubei Biocause offers products such as ibuprofen, ibuprofen lysine, S-Ibuprofen, torasemide, fludarabine phosphate, gr …
  • Standard Alliance Insurance Plc (STDINSURE):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Standard Alliance Insurance Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric st …
  • Dantherm Power AS:企業のM&A・提携動向(エネルギー分野)
    Summary Dantherm Power A/S (Dantherm), subsidiary of Ballard Power Systems Inc, is an energy equipment manufacturing company which develops clean energy backup power systems. The company's products include direct hydrogen systems and methanol fueled systems. Dantherm provides proton exchange membran …
  • OVATION Pharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OVATION Pharmaceuticals, Inc. M …
  • Biom’Up SAS:企業のM&A・提携動向(医療機器分野)
    Summary Biom'Up SAS (Biom'Up) is a medical device company that designs, develops and manufactures innovative implantable medical devices. The company's products include covamesh, hemosnow, cova and matri bone, among others. It offers collagens, resorbable polymers and medical biomaterials. Biom'Up f …
  • EFG Hermes Holding SAE:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' EFG Hermes Holding SAE Mergers …
  • Japan U-Pica Company, Ltd. (7891):企業概要、財務及び戦略的SWOT分析
    Summary JAPAN U-PICA COMPANY, LTD. (U-Pica) manufactures and sells unsaturated polester resins, epoxy acrylate resins, coating resins and methacrylic ester monomers. Its products include BIOMUP biomass polyester resin, CFRP for CBZ, powder coatings BIOMUP, HAA curable powder coatings, yupikakoto, U- …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆